FOLH1 and posterior cortical atrophy: In particular, the oncological outcomes of this salvage surgery have not yet been clearly defined and are currently being investigated in prospective studies: TRACE-II trial (PSMA-RGS + short-term ADT vs. short-term ADT only- NCT05555017) and PEACE V trial (STORM-NCT03569241) designed for nodal recurrent oligorecurrent PCa [metastasis-directed therapy (MDT surgical or RT) vs. MDT + long-term ADT] [22,23].